The use of luspatercept for thalassemia in adults

Cappellini, MD; Taher, AT

Cappellini, MD (corresponding author), Univ Milan, Via F Sforza 35, I-20122 Milan, Italy.

BLOOD ADVANCES, 2021; 5 (1): 326

Abstract

Luspatercept is an activin receptor ligand trap that has been shown to enhance late-stage erythropoiesis in animal models of beta-thalassemia. A multi......

Full Text Link